3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
7
Multiple Myeloma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Down Syndrome
2
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
asciminib
7
Cyclophosphamide
6
fludarabine phosphate
5
fludarabine
4
nilotinib
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Imatinib Mesylate
3
venetoclax
2
Thiotepa
2
Tacrolimus
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Dasatinib
2
Cyclosporine
2
treosulfan
1
thymoglobulin
1
selinexor
1
ponatinib
1
olverembatinib
1
midostaurin
1
merphos
1
gilteritinib
1
bosutinib
1
blinatumomab
1
aldesleukin
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Mesna
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
auricularum
×
30 days
×
Clear all
No trials found.